Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
JAMA network open - United States
doi 10.1001/jamanetworkopen.2019.18668
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 8, 2020
Authors
Publisher
American Medical Association (AMA)